Mesoblast Stock (NASDAQ: MESO) stock price, news, charts, stock research, profile.
You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.
Other companies in Mesoblast’s space includes: Immunome (NASDAQ:IMNM), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).
Mesoblast has a consensus price target of $8.17.
The stock price for Mesoblast (NASDAQ: MESO) is $8.08 last updated October 1, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Mesoblast.
Mesoblast’s Q4 earnings are confirmed for Thursday, November 28, 2024.
There is no upcoming split for Mesoblast.
Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.